Accendra director granted 31,191 restricted shares

Kline Teresa L. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kline Teresa L. reported acquisition or exercise transactions in this Form 4 filing.

Accendra Health Inc. director Teresa L. Kline received a grant of 31,191 shares of common stock as equity compensation. The shares were awarded at no cash cost to her and are structured as restricted stock. Following this grant, she directly holds 85,316 common shares.

The restricted stock grant will vest on the earlier of one year from the grant date or the date of the next annual meeting that occurs at least 50 weeks after the grant date, aligning the director’s compensation with shareholder interests over that period.

Insider Trade Summary

Grant/Award: 31,191 shares

Grant/Award 1 txn

Insider Kline Teresa L.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	31,191	$0.00	$0.00

Holdings After Transaction: Common Stock — 85,316 shares (Direct)

Footnotes (1)

1. F1. Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

Key Figures

Restricted stock grant: 31,191 shares Grant price per share: $0.0000 per share Shares held after grant: 85,316 shares

3 metrics

Restricted stock grant 31,191 shares Common Stock awarded on 2026-05-14

Grant price per share $0.0000 per share Restricted stock compensation, not market purchase

Shares held after grant 85,316 shares Total direct common stock holdings after transaction

Key Terms

Restricted stock, Grant, award, or other acquisition, Common Stock, vesting

4 terms

Restricted stock financial

"Restricted stock grant which vests the earlier of (i) one year from the grant date"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vesting financial

"Restricted stock grant which vests the earlier of (i) one year from the grant date"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Accendra Health (ACH) director Teresa L. Kline report in this Form 4?

Teresa L. Kline reported receiving a grant of 31,191 shares of Accendra Health common stock as restricted stock. This is equity compensation rather than a market purchase and increases her direct holdings to 85,316 shares after the transaction.

How many Accendra Health (ACH) shares did Teresa L. Kline receive and at what price?

She received 31,191 shares of Accendra Health common stock at a stated price of $0.0000 per share. This indicates a compensation grant, not an open-market transaction, and reflects stock-based pay for her service as a director.

When do the restricted shares granted to Teresa L. Kline in ACH vest?

The restricted stock vests on the earlier of one year from the grant date or the date of the next annual meeting that is at least 50 weeks after the grant date. This schedule ties her compensation to continued board service.

What are Teresa L. Kline’s total Accendra Health (ACH) holdings after this grant?

After the reported restricted stock grant, Teresa L. Kline directly holds 85,316 shares of Accendra Health common stock. This figure reflects her position immediately following the award disclosed in the Form 4 filing.

Is Teresa L. Kline’s Form 4 transaction in ACH a buy or a compensation grant?

The transaction is classified as a grant, award, or other acquisition of shares, not an open-market buy. She acquired 31,191 restricted shares as equity compensation, with vesting based on time and the timing of the next annual meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 09:13 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kline Teresa L.

(Last) (First) (Middle)

ACCENDRA HEALTH, INC.

4435 WATERFRONT DRIVE

(Street)

GLEN ALLEN VIRGINIA 23060

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACCENDRA HEALTH INC/VA/ [ ACH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	05/14/2026		A		31,191	A	$0	85,316	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.

	Teresa L. Kline by Rosemarie France, POA	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)